Minyong Kang

23PUBLICATIONS
81CO-AUTHORS
Molecular targetsMedical physicsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 09, 2026
Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer.

Chung Un Lee, Seon-Yong Yeom, Wan Song

|Jan 09, 2026
Enhancing Risk Stratification in Equivocal Prostate Magnetic Resonance Imaging Lesions: Clinical Utility of Prostate Health Index and Prostate Health Index Density in Prostate Imaging-Reporting and Data System 3.

Jiwoong Yu, Sang Ah Chi, Minyong Kang

|Mar 07, 2025
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma.

Jiwoong Yu, Hyeonju Ahn, Kyung Yeon Han

|Mar 06, 2025
Diagnostic value of prostate health index in patients with no index lesion on mpMRI or negative previous combined biopsy.

Seong Soo Jeon, Wan Song, Minyong Kang

|Nov 26, 2024
Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database.

Chan Ho Lee, Minyong Kang, Cheol Kwak

|Sep 09, 2024
Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis.

Kunwoo Lee, Jiwoong Yu, Wan Song

Pageof 4

Frequent Collaborators

17 joint publications

Seong Il Seo

14 joint publications

Seong Soo Jeon

12 joint publications

Byong Chang Jeong

12 joint publications

Hwang Gyun Jeon